AR087993A1 - Procesos e intermediarios para la preparacion de un inhibidor macrociclico de la proteasa del hcv - Google Patents

Procesos e intermediarios para la preparacion de un inhibidor macrociclico de la proteasa del hcv

Info

Publication number
AR087993A1
AR087993A1 ARP120103498A AR087993A1 AR 087993 A1 AR087993 A1 AR 087993A1 AR P120103498 A ARP120103498 A AR P120103498A AR 087993 A1 AR087993 A1 AR 087993A1
Authority
AR
Argentina
Prior art keywords
formula
acid
cinconidine
preparation
organic solvent
Prior art date
Application number
Other languages
English (en)
Original Assignee
Janssen Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceuticals Inc filed Critical Janssen Pharmaceuticals Inc
Publication of AR087993A1 publication Critical patent/AR087993A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00—Preparation of carboxylic acid amides
    • C07C231/12—Preparation of carboxylic acid amides by reactions not involving the formation of carboxamide groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00—Preparation of carboxylic acid amides
    • C07C231/16—Preparation of optical isomers
    • C07C231/18—Preparation of optical isomers by stereospecific synthesis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/40—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/70—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/82—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton with the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a ring other than a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/70—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/84—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton with the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/06—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
    • C07D453/04—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems having a quinolyl-4, a substituted quinolyl-4 or a alkylenedioxy-quinolyl-4 radical linked through only one carbon atom, attached in position 2, e.g. quinine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/08—Bridged systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Furan Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Reivindicación 1: Un proceso para la preparación de una sal de cinconidina de la fórmula (4) que comprende los siguientes pasos: (a) someter al ácido 4-oxo-1,2-ciclopentandicarboxílico de fórmula (5) a reducción en un ambiente acuoso, para producir así una solución acuosa del ácido 4-hidroxi-1,2-ciclopentandicarboxílico racémico de fórmula (6); (b) agregar un solvente orgánico (por ej. un solvente orgánico miscible con agua) a la solución acuosa obtenida en (a); (c) someter al hidroxiácido racémico de fórmula (6) a ciclación a fin de obtener una solución acuosa de solventes orgánicos del correspondiente ácido racémico de lactona de fórmula (2); (d) agregar cinconidina a la solución acuosa de solvente orgánico obtenida en (c) para obtener la sal de cinconidina de fórmula (3) del ácido de lactona; (e) dejar que la sal de cinconidina cristalice para obtener la sal de cinconidina cristalina enantioméricamente purificada del ácido de lactona de fórmula (4).
ARP120103498 2011-09-22 2012-09-21 Procesos e intermediarios para la preparacion de un inhibidor macrociclico de la proteasa del hcv AR087993A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP11182375 2011-09-22

Publications (1)

Publication Number Publication Date
AR087993A1 true AR087993A1 (es) 2014-04-30

Family

ID=46924427

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP120103498 AR087993A1 (es) 2011-09-22 2012-09-21 Procesos e intermediarios para la preparacion de un inhibidor macrociclico de la proteasa del hcv

Country Status (16)

Country Link
US (1) US9227965B2 (es)
EP (1) EP2758386A1 (es)
JP (1) JP6235473B2 (es)
KR (1) KR20140063726A (es)
CN (2) CN103906739B (es)
AR (1) AR087993A1 (es)
AU (1) AU2012311461B2 (es)
BR (1) BR112014006984A2 (es)
CA (1) CA2845720A1 (es)
CL (1) CL2014000687A1 (es)
EA (1) EA201490675A1 (es)
HK (1) HK1199449A1 (es)
IL (1) IL231024A (es)
MX (1) MX356686B (es)
TW (1) TWI565704B (es)
WO (1) WO2013041655A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MA41812A (fr) 2015-03-27 2018-01-30 Janssen Pharmaceuticals Inc Procédés et intermédiaires pour la préparation d'un inhibiteur de protéase macrocyclique du vhc

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE461209T1 (de) 2004-01-30 2010-04-15 Medivir Ab Hcv ns-3 serine protease inhibitoren
PE20070211A1 (es) 2005-07-29 2007-05-12 Medivir Ab Compuestos macrociclicos como inhibidores del virus de hepatitis c
US8212043B2 (en) 2007-02-01 2012-07-03 Janssen R&D Ireland Processes and intermediates for preparing a macrocyclic protease inhibitor of HCV
US8426360B2 (en) * 2007-11-13 2013-04-23 Enanta Pharmaceuticals, Inc. Carbocyclic oxime hepatitis C virus serine protease inhibitors
US8927722B2 (en) * 2008-12-23 2015-01-06 Janssen Pharmaceutica N.V. Processes and intermediates for preparing a macrocyclic protease inhibitor of HCV
CN102741270B (zh) * 2009-09-28 2015-07-22 英特穆恩公司 C型肝炎病毒复制的环肽抑制剂
AU2011229164B2 (en) 2010-03-16 2015-11-26 Janssen Pharmaceuticals, Inc. Processes and intermediates for preparing a macrocyclic protease inhibitor of HCV

Also Published As

Publication number Publication date
US20140228574A1 (en) 2014-08-14
BR112014006984A2 (pt) 2017-04-04
US9227965B2 (en) 2016-01-05
HK1199449A1 (en) 2015-07-03
CL2014000687A1 (es) 2014-08-01
IL231024A (en) 2017-09-28
WO2013041655A1 (en) 2013-03-28
JP2014528943A (ja) 2014-10-30
CN103906739A (zh) 2014-07-02
CN107011339A (zh) 2017-08-04
EP2758386A1 (en) 2014-07-30
JP6235473B2 (ja) 2017-11-22
AU2012311461A1 (en) 2014-03-06
CA2845720A1 (en) 2013-03-28
KR20140063726A (ko) 2014-05-27
CN103906739B (zh) 2016-12-28
TW201329074A (zh) 2013-07-16
EA201490675A1 (ru) 2014-08-29
TWI565704B (zh) 2017-01-11
IL231024A0 (en) 2014-03-31
AU2012311461B2 (en) 2017-07-06
MX2014003509A (es) 2014-07-22
MX356686B (es) 2018-06-07

Similar Documents

Publication Publication Date Title
AR076027A1 (es) Metodos e intermediarios para la preparacion de agentes farmaceuticos
ES2564319T3 (es) Desalinización de agua utilizando una extracción por disolventes direccionales
ES2634490T3 (es) Derivados de ácido napht-2-ylacetico para tratar el sida
AR107649A1 (es) Método para producir d-psicosa de alta pureza
AR089651A1 (es) Composiciones colectoras y metodos para utilizar las mismas
AR093659A1 (es) Derivados ciclicos de nucleosidos y usos de los mismos
AR103930A1 (es) Proceso para preparar mesotriona
BR112013030830A2 (pt) processo de preparação de composto da fórmula (i) e estetrol obtido diretamente por meio do processo
PE20121824A1 (es) Proceso para preparar y purificar acidos grasos
AR103230A1 (es) Procesos para la preparación de un compuesto de diariltiohidantoína
AR082737A1 (es) Remojo y lavado concentrado
CL2019000878A1 (es) Una solución termosensible y método para su uso.
UY33325A (es) Purificación mediante adsorción de colorante caramelo
EA201290872A1 (ru) Способ получения бензоксаборолов
EA201990163A1 (ru) Консервация микроорганизмов
CL2016002546A1 (es) Método para procesar una corriente hemicelulósica acuosa con un alcohol alquílico a temperatura elevada y ph ácido y separar la mezcla obtenida.
AR085712A1 (es) Solucion de limpieza de colon
CO6700138A1 (es) Procedimiento de preparación de sal de l-arginina de perindoprilo
MX2019000031A (es) Procedimientos para la preparación de una solución de levotiroxina.
AR096917A1 (es) Proceso para la preparación de sales herbicidas de ácido carboxílico
CL2016000516A1 (es) Método y sistema de preparación de carbonato de litio de alta pureza.
CL2015000957A1 (es) Métodos para reducir la formación de encrustante
UY37502A (es) Dinucleótido cíclico
ES2571043T3 (es) Preparación de dihidropiridinas
MX2016007117A (es) Barra de jabon.

Legal Events

Date Code Title Description
FB Suspension of granting procedure